Health and Fitness Health and Fitness
Thu, March 1, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
la Gestion des paiements
Wed, February 29, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
Epic Data Announces Q1 Results

Synta to Present at the Cowen and Company 32nd Annual Health Care Conference


Published on 2012-02-29 13:27:06 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will be presenting at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7 at 8:00 a.m. (ET) in Boston.

A live audio [ webcast ] and replay of the panel will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].